Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cordstem-ST in Cerebral Infarction
NCT02378974Phase 2Completed
- Sponsor
- CHA Biotech
- Start
- Feb 2015
- Primary completion
- Apr 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CordSTEM-ST in cerebral infarction (2 cohorts), sponsored by CHA Biotech. Primary endpoint: Number of Treatment-Emergent Adverse Events at 6 months. Started Feb 2015; status: completed.
02
Drugs
CordSTEM-ST
03
Conditions
cerebral infarction
Beyond the preview
Go deeper on NCT02378974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378974.